statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	588
IT - Italia	231
VN - Vietnam	171
SG - Singapore	100
DE - Germania	84
CN - Cina	83
GB - Regno Unito	42
SE - Svezia	41
NL - Olanda	35
BR - Brasile	34
HK - Hong Kong	32
FR - Francia	24
IN - India	22
FI - Finlandia	18
CI - Costa d'Avorio	17
RU - Federazione Russa	12
BG - Bulgaria	10
IE - Irlanda	9
CH - Svizzera	8
PL - Polonia	7
TG - Togo	7
ZA - Sudafrica	7
BD - Bangladesh	6
JO - Giordania	6
PH - Filippine	5
TH - Thailandia	5
TR - Turchia	5
AR - Argentina	4
AT - Austria	4
BE - Belgio	4
CA - Canada	4
ID - Indonesia	4
UA - Ucraina	4
DK - Danimarca	3
IQ - Iraq	3
JP - Giappone	3
KR - Corea	3
MX - Messico	3
SC - Seychelles	3
EC - Ecuador	2
EE - Estonia	2
HR - Croazia	2
HU - Ungheria	2
KE - Kenya	2
NG - Nigeria	2
PK - Pakistan	2
PY - Paraguay	2
UZ - Uzbekistan	2
AL - Albania	1
AU - Australia	1
BO - Bolivia	1
DO - Repubblica Dominicana	1
EG - Egitto	1
LA - Repubblica Popolare Democratica del Laos	1
MA - Marocco	1
PS - Palestinian Territory	1
SA - Arabia Saudita	1
SN - Senegal	1
VE - Venezuela	1
Totale	1.680

Nome	#
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft	340
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations	324
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma	285
Virus-like particle display of HER2 induces potent anti-cancer responses	232
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression	219
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response	180
Xenografting Human Musculoskeletal Sarcomas in Mice, Chick Embryo, and Zebrafish: How to Boost Translational Research	79
Functional stability, progression and evolution of targeted drug sensitivity of HER-2-positive breast cancer patient-derived xenografts	67
Totale	1.726

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	67	0	0	0	0	0	0	0	0	0	0	0	67
2021/2022	222	8	9	16	6	20	26	6	22	22	28	36	23
2022/2023	243	22	30	24	39	16	17	8	6	31	11	23	16
2023/2024	61	8	6	4	9	3	6	5	5	3	7	0	5
2024/2025	283	16	41	32	20	22	14	21	15	9	34	21	38
2025/2026	549	54	50	46	34	48	17	72	15	128	54	18	13
Totale													1.726

CRIS Current Research Information System